Financial Health Report: Cabaletta Bio Inc (CABA)’s Ratios Tell a Tale

Ulysses Smith

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

Cabaletta Bio Inc (NASDAQ: CABA) closed the day trading at $2.18 up 13.54% from the previous closing price of $1.92. In other words, the price has increased by $13.54 from its previous closing price. On the day, 3.27 million shares were traded. CABA stock price reached its highest trading level at $2.2298 during the session, while it also had its lowest trading level at $1.9325.

Ratios:

For a better understanding of CABA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.78 and its Current Ratio is at 4.78. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of. The Stock’s future direction. In the most recent recommendation for the company, Evercore ISI on December 20, 2024, Downgraded its rating to In-line and sets its target price to $6 from $15 previously.

On December 19, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $12 to $6. On October 10, 2024, UBS started tracking. The Stock assigning a Buy rating and target price of $10.UBS initiated its Buy rating on October 10, 2024, with a $10 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 199394208 and an Enterprise Value of 29605208.

Stock Price History:

The Beta on a monthly basis for CABA is 2.93, which has changed by -0.53617024 over the last 52 weeks, in comparison to a change of 0.16298151 over the same period for the S&P500. Over the past 52 weeks, CABA has reached a high of $5.46, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of. The Stock is 33.69%, while the 200-Day Moving Average is calculated to be 15.25%.

Shares Statistics:

Over the past 3-months, CABA traded about 1.56M shares per day on average, while over the past 10 days, CABA traded about 1982570 shares per day. A total of 91.45M shares are outstanding, with a floating share count of 79.01M. Insiders hold about 13.61% of the company’s shares, while institutions hold 68.30% stake in the company. Shares short for CABA as of 1756425600 were 5823233 with a Short Ratio of 3.74, compared to 1753920000 on 6025514. Therefore, it implies a Short% of Shares Outstanding of 5823233 and a Short% of Float of 6.4799999999999995.

Earnings Estimates

The current market rating for Cabaletta Bio Inc (CABA) reflects the collective analysis of 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.38 and low estimates of -$0.68.

Analysts are recommending an EPS of between -$1.84 and -$2.7 for the fiscal current year, implying an average EPS of -$2.32. EPS for the following year is -$1.66, with 6.0 analysts recommending between -$1.04 and -$2.2.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.